Task order #2 for "continuous rodent and non-rodent pharmacokinetic assessments"
Ended Awarded Last action
- Contract number
- HHSN27100002
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $809,627
Award facts
- Opportunity
-
- TORFPNONIHNINDS1707 Solicitation number
- Contract value 100% obligated
- $809,626.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$98,171 | |
| Funding Only Action | -$70,931 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $346,478 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $327,020 | |
| Supplemental Agreement for work within scope | $52,168 | |
| Original award | $253,062 |
About this award
This is a task order for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments" awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The task order is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle called the Pharmacology and Toxicology for Therapeutics Program (PTTP), which provides preclinical services to support drug discovery and development. The task order has a potential value of $809,626.71 and is a Cost Plus Fixed Fee type contract. It does not have a set-aside designation. Southern Research Institute has previously provided a range of research, testing, and manufacturing services to various federal agencies, including the NIH, CDC, DoD, and EPA, on topics such as drug discovery, medical countermeasures, and environmental research.
Quick answers
Who was awarded contract HHSN27100002?
HHSN27100002 was awarded to Southern Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 22, 2017.
How much is contract HHSN27100002 worth?
The government has obligated $809,627 on HHSN27100002.
Which agency awarded contract HHSN27100002?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN27100002, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract HHSN27100002 an order under another contract?
Yes. HHSN27100002 is a delivery order under HHSN271201600007I, an indefinite delivery contract, on Pharmacology and Toxicology for Therapeutics Program (PTTP).
Was contract HHSN27100002 competed?
The extent of competition for HHSN27100002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award